224 results on '"Calleri, Angelica"'
Search Results
2. Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphoma
3. Pre-existing immune checkpoints activation predicts relapse after allogeneic stem cell transplantation in lymphoma
4. Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified
5. Mediastinal Gray-Zone Lymphoma: Still an Open Issue
6. Gray-Zone Lymphoma: A Still Open Issue
7. Vinorelbine, cyclophosphamide and 5-FU effects on the circulating and intratumoural landscape of immune cells improve anti-PD-L1 efficacy in preclinical models of breast cancer and lymphoma
8. Supplementary Figure Legend from Therapeutic Effect of Lenalidomide in a Novel Xenograft Mouse Model of Human Blastic NK Cell Lymphoma/Blastic Plasmacytoid Dendritic Cell Neoplasm
9. Supplementary Figure 2 from Therapeutic Effect of Lenalidomide in a Novel Xenograft Mouse Model of Human Blastic NK Cell Lymphoma/Blastic Plasmacytoid Dendritic Cell Neoplasm
10. Supplementary Figure 1 from Therapeutic Effect of Lenalidomide in a Novel Xenograft Mouse Model of Human Blastic NK Cell Lymphoma/Blastic Plasmacytoid Dendritic Cell Neoplasm
11. Supplementary Figure Legends and Tables from Complementary Populations of Human Adipose CD34+ Progenitor Cells Promote Growth, Angiogenesis, and Metastasis of Breast Cancer
12. Supplementary Figures from Complementary Populations of Human Adipose CD34+ Progenitor Cells Promote Growth, Angiogenesis, and Metastasis of Breast Cancer
13. Data from The White Adipose Tissue Used in Lipotransfer Procedures Is a Rich Reservoir of CD34+ Progenitors Able to Promote Cancer Progression
14. Supplementary Video 1 from The White Adipose Tissue Used in Lipotransfer Procedures Is a Rich Reservoir of CD34+ Progenitors Able to Promote Cancer Progression
15. Data from Complementary Populations of Human Adipose CD34+ Progenitor Cells Promote Growth, Angiogenesis, and Metastasis of Breast Cancer
16. Supplementary Table 1 from The White Adipose Tissue Used in Lipotransfer Procedures Is a Rich Reservoir of CD34+ Progenitors Able to Promote Cancer Progression
17. Supplementary Figure Legends 1-5, Movie Legend 1 from The White Adipose Tissue Used in Lipotransfer Procedures Is a Rich Reservoir of CD34+ Progenitors Able to Promote Cancer Progression
18. Supplementary Figures 1-5 from The White Adipose Tissue Used in Lipotransfer Procedures Is a Rich Reservoir of CD34+ Progenitors Able to Promote Cancer Progression
19. Antiangiogenic therapy in recurrent breast cancer with lymphangitic spread to the chest wall: A randomized phase II trial of bevacizumab with sequential or concurrent oral vinorelbine and capecitabine
20. Cusatuzumab for treatment of CD70‐positive relapsed or refractory cutaneous T‐cell lymphoma
21. Circulating Endothelial Cells and Circulating Endothelial Progenitors
22. Correction: Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified
23. Addressing the Role of Angiogenesis in Patients with Advanced Pancreatic Neuroendocrine Tumors Treated with Everolimus: A Biological Prospective Analysis of Soluble Biomarkers and Clinical Outcomes
24. Circulating Endothelial Cells as a Novel Marker of Angiogenesis
25. Cytotoxic Epstein-Barr virus-positive large B cell lymphoma: a regulatory B cell-derived neoplasia?
26. CD38, BCL‐2, PD‐1, and PD‐1L expression in nodal peripheral T‐cell lymphoma: Possible biomarkers for novel targeted therapies?
27. Metronomic Chemotherapy Combined With Bevacizumab and Erlotinib in Patients With Metastatic HER2-Negative Breast Cancer: Clinical and Biological Activity
28. A three-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphoma
29. Peripheral T-Cell Lymphoma, Not Otherwise Specified: Clinical Manifestations, Diagnosis, and Future Treatment
30. Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphoma
31. The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells
32. Paradoxic effects of metformin on endothelial cells and angiogenesis
33. The identification of TCF1+progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockade
34. Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy
35. Circulating perivascular progenitors: A target of PDGFR inhibition
36. Evolutionary crossroads: morphological heterogeneity reflects divergent intra-clonal evolution in a case of high-grade B-cell lymphoma
37. Circulating endothelial cells (CECs) and progenitors (CEPs) in severe haemophiliacs with different clinical phenotype
38. Chlorambucil in combination with induction and maintenance rituximab is feasible and active in indolent non-Hodgkinʼs lymphoma
39. Immunological Evaluation of Patients with Beta-Thalassemia major
40. Recurrent PDL1 expression and PDL1 (CD274) copy number alterations in breast implant–associated anaplastic large cell lymphomas
41. Blastic Plasmacytoid Dendritic Cell Neoplasm: State of the Art and Prospects
42. Dissecting diffuse large B-cell lymphomas of the “not otherwise specified” type: the impact of molecular techniques
43. Argx-110 for Treatment of CD70-Positive Advanced Cutaneous T-Cell Lymphoma in a Phase 1/2 Clinical Trial
44. If it is in the marrow, is it also in the blood? An analysis of 1,000 paired samples from patients with B-cell non-Hodgkin lymphoma
45. Leukemia-associated NPM mutations promote quiescence of hematopoietic stem cells and prevent their functional exhaustion upon oncogene-induced hyper-proliferation
46. Cytotoxic Epstein-Barr virus-positive large B cell lymphoma: a regulatory B cell-derived neoplasia?
47. CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: Possible biomarkers for novel targeted therapies?
48. Whole exome sequencing reveals mutations in FAT1tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified
49. Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells
50. Molecular investigation of coexistent chronic myeloid leukaemia and peripheral T-cell lymphoma – a case report
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.